Retatrutide is a first-in-class triple hormone receptor agonist whose Phase 3 data, released through late 2025 and 2026, has pushed Canadian research interest to record highs
If you're considering or taking a GLP-1 drug and you also have food allergies, it's essential to have a conversation with your health care provider
Missing several doses in a row is different, because appetite and food noise tend to return, which can make the trip harder to manage
Set the vial down on a flat surface and wait 5 to 10 minutes
Effects of hydrogen sulphide donor, sodium hydrosulphide treatment on the erectile dysfunction in L-NAME-induced hypertensive rats
In Canada, coverage for semaglutide varies by insurance plan, province, and the specific condition for which it is prescribed